Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$110.76 - $143.18 $55,380 - $71,590
-500 Reduced 6.87%
6,774 $760,000
Q2 2023

Jul 20, 2023

BUY
$126.43 - $145.6 $18,964 - $21,840
150 Added 2.11%
7,274 $1.06 Million
Q1 2023

May 15, 2023

BUY
$121.91 - $130.94 $406,691 - $436,815
3,336 Added 88.07%
7,124 $920,000
Q4 2022

Feb 07, 2023

SELL
$104.7 - $128.4 $43,031 - $52,772
-411 Reduced 9.79%
3,788 $482,000
Q3 2022

Oct 12, 2022

SELL
$101.65 - $119.27 $71,968 - $84,443
-708 Reduced 14.43%
4,199 $469,000
Q2 2022

Jul 22, 2022

SELL
$102.23 - $133.85 $13,187 - $17,266
-129 Reduced 2.56%
4,907 $526,000
Q1 2022

Apr 29, 2022

SELL
$108.42 - $129.58 $12,468 - $14,901
-115 Reduced 2.23%
5,036 $662,000
Q4 2021

Feb 23, 2022

BUY
$115.43 - $146.63 $594,579 - $755,291
5,151 New
5,151 $655,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.1B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track C2 C Wealth Management, LLC Portfolio

Follow C2 C Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C2 C Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on C2 C Wealth Management, LLC with notifications on news.